Paris Medicine Co. v. W. H. Hill Co.

102 F. 148, 42 C.C.A. 227, 1900 U.S. App. LEXIS 4528
Court of Appeals for the Sixth Circuit·Decided May 8, 1900·No. No. 764·Published·Cited by 14 cases

Opinion

LURTON, Circuit Judge,

after making the foregoing statement, delivered the opinion of the court.

It must he admitted that the resemblances between the trade-name and dress of the rival preparations here involved are numerous and striking. There are differences between their packages, including differences in the colors of the lettering thereon, but the differences are less observable than the resemblances. An intentional infringer is never likely to make his packages exactly like that of the tradesman whose trade he proposes to steal. To avoid the consequences of infringement, an intentional infringer will usually take care that there are plenty of what Judge Lacombe, in Scheuer v. Muller, 20 C. C. A. 161, 74 Fed. 225, 228, called “arguable differences,” to stand upon when brought into court, but resemblances to the article he desires to imitate sufficient' to deceive the average purchaser into buying the simulated article as and for the goods of another. Speaking of the infringement of a trade-mark, Justice Cotton, in Tea Co. v. Herbert, 7 Eng. Rep. Patents & Trade-Mark Cas. p. 183, said:

“Of course, wlien one person imitates another's mark, lie never takes it absolutely in all points. If so, there is no question. But there is always a similarity and dissimilarity, in order that he may say, ‘If you look at the marks carefully, you will see such a difference that you cannot be deceived.’ Of course, when you are told that there are two marks, and the differences pointed out, or they are put before you so that you can see the differences, then in that ease you might say there is hardly any probability of deception; but, when one only is shown, there are certain incautious purchasers who would probably be deceived by the similarities which exist, the articles being the same.”

[151] 'Wlien there are found strong resemblances, the natural inquiry for tbe court is, why do they exist? If no sufficient answer appears, the inference is that they exist for the purpose of misleading. Taylor v. Taylor, 2 Eq. Rep. 290. We are to remember that the average purchaser has seldom the opportunity of making a close comparison; that he is apt to act quickly, and is therefore not expected to exercise a high degree of caution. Pillsbury v. Flour-Mills Co., 12 C. C. A. 432, 64 Fed. 841.

In McLean v. Fleming, 96 U. S. 245, 255, 24 L. Ed. 832, the court said:

“Difficulty frequently arises in determining the question of infringement, but it is clear that exact similarity is not required, as that requirement, would always enable the wrongdoer to evade responsibility for his wrongful acts. Colorable imitation, which requires careful inspection to distinguish the spurious trade-mark from the genuine, is sufficient to maintain the issue, but a court of equity will not interfere wlien ordinary attention by the purchaser of the article would enable him at once to discriminate the one from the other. Where the similarity is sufficient to convey a false impression to the public mind, and is of a character to mislead and deceive the ordinary purchaser, in the exercise of ordinary care and caution in such matters, *it is sufficient to give the injured party a right to redress, if he has been guilty of no laches.”

The general resemblance between the names “Bromo Quinine” and “Bromide Quinine” is very striking. The words “Bromo Quinine” catch the eye and fasten themselves in the memory, and, as the name of the remedy, become easily known and recognizable. The difference between “Bromo Quinine” and “Bromide Quinine” is slight, and not likely to attract the attention of the average public. It is true that complainant uses the word “Laxative” as a prefix, but that is a word indicative of a therapeutic effect. The defendants have substituted “Cascara” as a prefix, that being a drug widely and generally known as one of the best laxatives. Ilere, again, is both a resemblance and a difference, by which the literalness of imitation is avoided, while the laxative property of the defendants’ “Bromide Quinine” is called to the attention of the public.

Free access — add to your briefcase to read the full text and ask questions with AI

Paris Medicine Co. v. W. H. Hill Co., 102 F. 148, 42 C.C.A. 227, 1900 U.S. App. LEXIS 4528 (6th Cir. 1900).

102 F. 148 (Paris Medicine Co. v. W. H. Hill Co.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Emra Corp. v. Superclips Ltd.
559 F. Supp. 705 (E.D. Michigan, 1983)
Black & Decker Mfg. v. Ever-Ready Appliance
518 F. Supp. 607 (E.D. Missouri, 1981)
T & T Manufacturing Co. v. A. T. Cross Co.
449 F. Supp. 813 (D. Rhode Island, 1978)
J. C. Penney Co. v. H. D. Lee Mercantile Co.
120 F.2d 949 (Eighth Circuit, 1941)
Shaler Co. v. Rite-Way Products, Inc.
19 F. Supp. 804 (W.D. Tennessee, 1937)
Paris Medicine Co. v. Brewer & Co.
17 F. Supp. 7 (D. Massachusetts, 1936)
Chesebrough Mfg. Co. v. Old Gold Chemical Co.
70 F.2d 383 (Sixth Circuit, 1934)
Coca-Cola Co. v. Carlisle Bottling Works
43 F.2d 101 (E.D. Kentucky, 1929)
McIlhenny Co. v. Bulliard
265 F. 705 (W.D. Louisiana, 1920)
Thomas Manufacturing Co. v. Æolian Co.
47 App. D.C. 376 (D.C. Circuit, 1918)
Sterling Remedy Co. v. Gorey
110 F. 372 (U.S. Circuit Court for the District of Northern Ohio, 1901)